Tandem Diabetes Care TNDM
NASDAQ TNDM
$18.41 -0.70 (-3.69%)
As of: Sep 10, 2026 · 2:22 PM EDT

Tandem Diabetes Care (TNDM) Short term Debt (2024 - 2025)

Tandem Diabetes Care's (TNDM) quarterly Short term Debt came in at $40.7 million in Q1 2025, little changed quarter-over-quarter from $40.7 million in Q4 2024.

Analysis

Tandem Diabetes Care (TNDM) Short term Debt (2024 - 2025) Analysis & Trends

Tandem Diabetes Care (TNDM) has reported Short term Debt for 2 consecutive years, with $40.7 million the latest figure, recorded in Q1 2025.

  • For the quarter ending Q1 2025, Short term Debt changed N/A year-over-year to $40.7 million; the trailing twelve-month figure through Mar 2025 stood at $40.7 million (changed N/A YoY), and the FY2024 full-year result was $40.7 million, changed N/A from the prior year.
  • Short term Debt was little changed at $40.7 million in Q1 2025 per TNDM's latest filing, from $40.7 million in the prior quarter.
  • Across five years, Short term Debt topped out at $40.7 million in Q1 2025 and bottomed at $40.5 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 180.78 Bn 175.17 Bn 7.27 Bn
2 Intuitive Surgical 127.04 Bn 121.82 Bn 1.96 Bn
3 Medtronic 117.04 Bn 108.22 Bn 6.34 Bn
4 Stryker 103.86 Bn 100.38 Bn 4.50 Bn
5 Boston Scientific 63.50 Bn 62.96 Bn 3.85 Bn
6 Edwards Lifesciences 49.74 Bn 45.49 Bn 1.35 Bn
7 Alcon 32.99 Bn 31.53 Bn 1.68 Bn
8 Dexcom 32.12 Bn 30.17 Bn 830.00 Mn
9 Steris 20.69 Bn 20.21 Bn 684.20 Mn
10 Tandem Diabetes Care 1.27 Bn 811.05 Mn 144.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 40.74 Mn
Dec 31, 2024 40.67 Mn
Sep 30, 2024 40.61 Mn
Jun 30, 2024 40.54 Mn